Kerry Dierberg

TL;DR: The findings underscore the need for early clinical follow-up of survivors of EVD and urgent provision of ocular care as part of health systems strengthening in EVD-affected west African countries.

TL;DR: How the international NGO Partners In Health partnered with the Government of Sierra Leone and Wellbody Alliance to respond to the EVD epidemic and how, in the aftermath of the epidemic, PIH is partnering with the public sector to strengthen the health system and resume delivery of regular health services is described.

TL;DR: By using ELISA to measure Zaire Ebola virus antibody concentrations, a significant number of individuals with previously undetected EBOV infection in a ‘hotspot’ village in Sierra Leone are identified, approximately one year after the village outbreak.

TL;DR: EBOV persistence by RT-PCR was not identified in ocular fluid or conjunctivae of fifty EVD survivors with ocular disease, and cataract surgery can be performed safely with vision restorative outcomes in patients who test negative for EBOV RNA in Ocular fluid specimens.

TL;DR: The Magazine Wharf area, Freetown, Sierra Leone was a focus of ongoing Ebola virus transmission from late June 2015 and viral genomes linked to this area contain a series of 13 T to C substitutions in a 150 base pair intergenic region downstream of viral protein 40 open reading frame, similar to the Ebolavirus/H.sapiens-wt/SLE/2014/Makona-J0169 strain.